Equities

Observe Medical ASA

Observe Medical ASA

Actions
  • Price (EUR)0.0288
  • Today's Change-0.003 / -8.28%
  • Shares traded--
  • 1 Year change+14.15%
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024 12:25 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of NOK
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments14142.86
Total Receivables, Net6.667.175.28
Total Inventory6.898.127.01
Prepaid expenses------
Other current assets, total------
Total current assets272915
Property, plant & equipment, net1.964.151.38
Goodwill, net10210034
Intangibles, net1228321
Long term investments------
Note receivable - long term------
Other long term assets0.03----
Total assets25421672
LIABILITIES
Accounts payable188.616.16
Accrued expenses116.073.75
Notes payable/short-term debt0456.51
Current portion long-term debt/capital leases4.48----
Other current liabilities, total281356
Total current liabilities617272
Total long term debt501.910.55
Total debt55477.06
Deferred income tax------
Minority interest------
Other liabilities, total273.3713
Total liabilities1387886
SHAREHOLDERS EQUITY
Common stock------
Additional paid-in capital------
Retained earnings (accumulated deficit)------
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total116138(14)
Total equity116138(14)
Total liabilities & shareholders' equity25421672
Total common shares outstanding1917936
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.